Sunday, 25 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Medical Device
China’s First Proton Therapy System Approved by NMPA
February 4, 2025
Company
Drug
Brii Biosciences Publishes Positive Phase I Results for PPD Therapy BRII-296
February 4, 2025
Company
Drug
Sino Biopharmaceutical’s TDI01 Receives Clinical Trial Approval for COVID-19
February 4, 2025
Company
China Resources Pharma Reports Strong Interim Results Amid COVID-19
February 4, 2025
Company
Deals
Sciwind Biosciences Partners with SynerK for siRNA Therapeutics Development
February 4, 2025
Company
Drug
Arctic Vision Administers First Injection of ARVN001 for Uveitis Macular Edema
February 4, 2025
Company
Deals
Synthgene Partners with Micor&Nano for Comprehensive Solutions in Nucleic Acid Drugs
February 4, 2025
Company
Deals
ThunderBio Secures Funding from Guangzhou LBP for PCR Innovation
February 4, 2025
Company
Drug
Fujian Cosunter Receives NMPA Approval for COVID-19 Drug Candidate GST-HG171
February 4, 2025
Company
Drug
Everest Medicines Gains CDE Approval for EVER001 Phase Ib Study
February 4, 2025
Company
Medical Device
Boston Scientific Completes First Surgery with RotaPro in China
February 4, 2025
Company
Sihuan Pharmaceutical Reports Decline in Revenues Amid COVID-19 Lockdowns
February 4, 2025
1
2
3
4
5
6
7
…
19
20
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
